BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [PMID: 35070787 DOI: 10.5500/wjt.v11.i12.512]
URL: https://www.wjgnet.com/2220-3230/full/v11/i12/512.htm
Number Citing Articles
1
Dafna Yahav, Melissa R Gitman, Ili Margalit, Tomer Avni, Mariska M G Leeflang, Shahid Husain. Screening for Latent Tuberculosis Infection in Solid Organ Transplant Recipients to Predict Active Disease: A Systematic Review and Meta-Analysis of Diagnostic StudiesOpen Forum Infectious Diseases 2023; 10(8) doi: 10.1093/ofid/ofad324
2
Carlo Foppiano Palacios, Natalia Medvedeva, Harry Cheung, Elizabeth Cohen, Marwan M. Azar, Maricar Malinis. The cascade of care in testing and treatment of latent tuberculosis infection in liver transplant candidatesTransplant Infectious Disease 2023; 25(1) doi: 10.1111/tid.13999
3
Jorge Cardenas, Maria E. Campos-Bonaguro, Jacques Simkins. Latent tuberculosis infection in liver transplant patients: a reviewClinical Liver Disease 2023; 21(1): 1 doi: 10.1097/CLD.0000000000000003
4
Seiyed Mohammad Ali Ghayumi, Alireza Shamsaeefar, Nasrin Motazedian, Amirali Mashhadiagha, Mehrab Sayadi, Saman Nikeghbalian, Seyed Ali Malekhosseini. Isoniazid prophylaxis in liver transplant recipient with latent tuberculosis: Is it harmful for transplanted liver?Transplant Infectious Disease 2022; 24(4) doi: 10.1111/tid.13849